Avanos Medical (AVNS)
(Delayed Data from NYSE)
$10.98 USD
-0.19 (-1.70%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $10.99 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AVNS 10.98 -0.19(-1.70%)
Will AVNS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AVNS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVNS
New Strong Sell Stocks for July 15th
Avanos Medical (AVNS) International Revenue in Focus: Trends and Expectations
AVNS: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Sell Stocks for May 9th
AVNS Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates
Other News for AVNS
Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical | AVNS ...
Avanos announces divestiture of Hyaluronic Acid product line to Channel-Markers Medical
Avanos divests Hyaluronic Acid product line to Channel-Markers Medical
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2025 Financial ...
Avanos (AVNS) Welcomes New Chief Human Resources Officer | AVNS Stock News